LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Ashraf, Sadaf (2011)
Languages: English
Types: Unknown
Subjects:
Background: Osteoarthritis (OA), one of the commonest joint diseases of unknown aetiology is a major source of pain and disability in the ageing population. Current therapeutic agents for OA focus on symptomatic relief. Patients often present to clinics with long established disease when the boundaries between ageing and pathology are indistinct. A greater understanding of early OA is thus required and may help achieve the goal of disease modification. OA is associated with chondropathy, synovitis, subchondral bone remodelling and osteophyte formation. Angiogenesis, the growth of new blood vessels from pre-existing ones may contribute to each of these features. Inflammation is increasingly recognised as an important feature of OA. Synovitis is detectable within the osteoarthritic joint both radiologically and histologically, evidenced by symptoms such as stiffness or pain, signs such as effusion and use of anti-inflammatory drugs for treatment of OA. Pain is the predominant symptom of OA, but little is known about the mechanism by which this pain arises. Objectives: This thesis describes studies examining the contributions of angiogenesis to inflammation, structural damage and pain in OA. Hypothesis: Inflammation and angiogenesis are co-dependent processes that can exacerbate and mediate structural damage and pain in OA. Methods: In-vivo, in animal models and ex-vivo in human meniscal tissue, using immunohistochemistry, joint histology and pain behaviour testing, the effects of enhancing synovitis on angiogenesis, structural damage and pain in OA, and whether inhibiting either synovitis or angiogenesis could reduce this structural damage and pain were investigated. Results: It is shown for the first time that blood vessel growth at the onset of resolving synovitis leads to its subsequent persistence. Exacerbating synovitis in the rat meniscal transection (MNX) model of OA enhanced synovial angiogenesis, total joint damage and pain behaviour. Following treatment with the anti-angiogenic compound, PPI-2458 [(1R)-1-carbamoyl-2-methyl]-carbamic acid-(3R, 3S, 5S, 6R)-5-methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl) oxiranyl]-1-oxaspiro (2*5) oct-6-yl ester], synovial angiogenesis, vascularisation of channels penetrating into the articular cartilage (osteochondral angiogenesis), synovitis, joint damage (mainly attenuation of osteophyte growth) and pain behaviour were all reduced. Anti-inflammatory drugs (dexamethasone and indomethacin) reduced synovitis, synovial angiogenesis and pain behaviour in the rat MNX model of OA. Treatment with dexamethasone reduced joint damage score by decreasing cartilage damage. Indomethacin however did not affect joint structure. Human meniscal tissue from knees with high chondropathy displayed increased degeneration of collagen bundles, increased vascular densities both in the synovium and at the fibrocartilage junction with a greater density of perivascular sensory nerve profiles in the outer region. Increased penetration of the synovial tissue towards the tip of the meniscus was noted in menisci from high chondropathy group compared to those from the low chondropathy group. Conclusion: Data from animal studies indicates that conversion of acute inflammation to chronic inflammation may be due to the stimulation of angiogenesis. Furthermore, these data provide evidence that synovitis contributes to joint pathology and pain behaviour in the rat MNX model of OA and this may be partly due to the angiogenesis in the synovium and at the osteochondral junction. Data from human studies highlights that tibiofemoral chondropathy is associated with altered matrix structure, increased vascular penetration and increased sensory nerve densities in the medial meniscus. Angiogenesis and associated sensory nerves in the meniscus may therefore contribute to pain in knee OA. Summary: These findings support the hypothesis that inflammation and angiogenesis are indeed co-dependent processes, exacerbating and mediating structural damage and pain in OA. Angiogenesis inhibition has the potential to reduce synovitis, joint damage and pain in OA.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1.8 Animal Models of Osteoarthritis
    • 1.9 Summary
    • 1.10 Hypothesis and Aims
    • 2.1 Introduction
    • 2.2 Animal Models 2.2.1 Anaesthesia 2.2.2 Euthanasia 2.2.3 Intra-articular injection into rat knee joints 2.2.4 Subcutaneous Injections 2.2.5 Oral Gavage 2.2.6 Meniscal Transection (MNX) Model of Osteoarthritis 2.3 Behavioural Testing 2.3.1 Pain Testing 2.3.2 Weights
    • 2.4 Joint Swelling
    • 2.5 Tissue Collection and Processing 2.5.1 Harvesting and Mounting Rat Synovia 2.5.2 Harvesting and Mounting Rat Tibiofemoral Joints 2.5.3 Human Menisci 2.5.4 Systemic Transcardiac Perfusion of Rat Tibiofemoral Joints 2.5.5 Blood Glucose Testing
    • 2.6 Immunohistochemistry 2.6.1 Introduction 2.6.2 Principles Involved 2.6.3 Staining Procedures
    • 2.7 Histological Stains 2.7.1 Haematoxylin and Eosin 2.7.2 Safranin-O and fast green
    • 2.8 Image Analysis and Quantification 2.8.1 Synovia 2.8.2 Cartilage and Subchondral Bone 2.8.3 Human Menisci
    • 2.9 Patient and Sample Selection for Human Menisci Study 2.9.1 Macroscopic Chondropathy Score of Tibiofemoral Joint 2.10 Statistical Analysis
    • 2.11 Reagents
    • 56 59 60 61 61 61 61 62 62 63 63 63 66 66 67 67 68 68 68 70 70 71 71 71 71 73 76 76 76 77 77 78 79 81 81 86 86 Priest, R. C., Spaull, J., Buckton, J., Grimley, R. L., Sims, M., Binks, M. and Malhotra, R. (2009). "Immunomodulatory activity of a methionine aminopeptidase-2 inhibitor on B cell differentiation." Clin Exp Immunol 155(3): 514-22.
    • Pufe, T., Kurz, B., Petersen, W., Varoga, D., Mentlein, R., Kulow, S., Lemke, A. and Tillmann, B. (2005). "The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system." Ann Anat 187(5-6): 461-72.
    • Pufe, T., Lemke, A., Kurz, B., Petersen, W., Tillmann, B., Grodzinsky, A. J. and Mentlein, R. (2004). "Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor." Am J Pathol 164(1): 185-92.
    • Qu, Z., Huang, X. N., Ahmadi, P., Andresevic, J., Planck, S. R., Hart, C. E. and Rosenbaum, J. T. (1995). "Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease." Lab Invest 73(3): 339-46.
    • Rashad, S., Revell, P., Hemingway, A., Low, F., Rainsford, K. and Walker, F. (1989). "Effect of nonsteroidal anti-inflammatory drugs on the course of osteoarthritis." Lancet 2(8662): 519-22.
    • Ray, B. K., Shakya, A. and Ray, A. (2007). "Vascular endothelial growth factor expression in arthritic joint is regulated by SAF-1 transcription factor." J Immunol 178(3): 1774-82.
    • Reginster, J. Y. and Khaltaev, N. G. (2002). "Introduction and WHO perspective on the global burden of musculoskeletal conditions." Rheumatology (Oxford) 41 Supp 1: 1-2.
    • Reimann, I. and Christensen, S. B. (1977). "A histological demonstration of nerves in subchondral bone." Acta Orthop Scand 48(4): 345-52.
    • Reyes-Llerena, G. A., Guibert-Toledano, M., Penedo-Coello, A., Perez-Rodriguez, A., Baez-Duenas, R. M., Charnicharo-Vidal, R. and Cardiel, M. H. (2009). "Community-Based Study to Estimate Prevalence and Burden of Illness of Rheumatic Diseases in Cuba: A COPCORD Study." J Clin Rheumatol 15(2): 51-55.
    • Rini, B. I. (2009). "Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma." Cancer 115(10 Suppl): 2306-12.
    • Risau, W. (1997). "Mechanisms of angiogenesis." Nature 386(6626): 671-4.
    • Rosenberg, L. (1971). "Chemical basis for the histological use of safranin O in the study of articular cartilage." J Bone Joint Surg Am 53(1): 69-82.
    • Rousseau, J. C. and Delmas, P. D. (2007). "Biological markers in osteoarthritis." Nat Clin Pract Rheumatol 3(6): 346-56.
    • Roussel, D., Dumas, J. F., Augeraud, A., Douay, O., Foussard, F., Malthiery, Y., Simard, G. and Ritz, P. (2003). "Dexamethasone treatment specifically increases the basal proton conductance of rat liver mitochondria." FEBS Lett 541(1-3): 75-9.
    • Saamanen, A. K., Salminen, H. J., Dean, P. B., De Crombrugghe, B., Vuorio, E. I. and Metsaranta, M. P. (2000). "Osteoarthritis-like lesions in transgenic mice harboring a small deletion mutation in type II collagen gene." Osteoarthritis Cartilage 8(4): 248-57.
    • Sin, N., Meng, L., Wang, M. Q., Wen, J. J., Bornmann, W. G. and Crews, C. M. (1997). "The antiangiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP2." Proc Natl Acad Sci U S A 94(12): 6099-103.
    • Slemenda, C., Heilman, D. K., Brandt, K. D., Katz, B. P., Mazzuca, S. A., Braunstein, E. M. and Byrd, D. (1998). "Reduced quadriceps strength relative to body weight: a risk factor for knee osteoarthritis in women?" Arthritis Rheum 41(11): 1951-9.
    • Smith, J., Hannon, R., Brunnberg, L., Gebski, V. and Cullis-Hill, D. (2002). "A multicentre clinical study of the efficacy of sodium pentosan polysulfate and carprofen canine osteoarthritis (osteoarthrosis)." Veterinarmotet.
    • Smith, J. O., Oreffo, R. O., Clarke, N. M. and Roach, H. I. (2003). "Changes in the antiangiogenic properties of articular cartilage in osteoarthritis." J Orthop Sci 8(6): 849-57.
    • Smith, M. D., Triantafillou, S., Parker, A., Youssef, P. P. and Coleman, M. (1997). "Synovial membrane inflammation and cytokine production in patients with early osteoarthritis." J Rheumatol 24(2): 365-71.
    • Smith, W. and Harrap, S. B. (1997). "Behavioural and cardiovascular responses of rats to euthanasia using carbon dioxide gas." Lab Anim 31(4): 337-46.
    • Sowers, M., Jannausch, M., Stein, E., Jamadar, D., Hochberg, M. and Lachance, L. (2002). "C-reactive protein as a biomarker of emergent osteoarthritis." Osteoarthritis Cartilage 10(8): 595-601.
    • Spector, T. D. and Cooper, C. (1993). "Radiographic assessment of osteoarthritis in population studies: whither Kellgren and Lawrence?" Osteoarthritis Cartilage 1(4): 203-6.
    • Stannus, O., Jones, G., Cicuttini, F., Parameswaran, V., Quinn, S., Burgess, J. and Ding, C. (2010). "Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults." Osteoarthritis Cartilage.
    • Stefanini, M., De Martino, C. and Zamboni, L. (1967). "Fixation of ejaculated spermatozoa for electron microscopy." Nature 216(5111): 173-4.
    • Storgard, C. M., Stupack, D. G., Jonczyk, A., Goodman, S. L., Fox, R. I. and Cheresh, D. A. (1999). "Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist." J Clin Invest 103(1): 47-54.
    • Streefkerk, J. G. (1972). "Inhibition of erythrocyte pseudoperoxidase activity by treatment with hydrogen peroxide following methanol." J Histochem Cytochem 20(10): 829-31.
    • Sun, Y., Mauerhan, D. R., Honeycutt, P. R., Kneisl, J. S., Norton, H. J., Zinchenko, N., Hanley, E. N., Jr. and Gruber, H. E. (2010). "Calcium deposition in osteoarthritic menisci and meniscal cell culture." Arthritis Res Ther 12(2): R56.
    • Sund, M., Zeisberg, M. and Kalluri, R. (2005). "Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application." Gastroenterology 129(6): 2076-91.
    • Suri, S., Gill, S. E., Massena de Camin, S., Wilson, D., McWilliams, D. F. and Walsh, D. A. (2007). "Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis." Ann Rheum Dis 66(11): 1423-8.
    • Swoboda, B. (2001). "[Epidemiological arthrosis research]." Orthopade 30(11): 834-40.
    • Szebenyi, B., Hollander, A. P., Dieppe, P., Quilty, B., Duddy, J., Clarke, S. and Kirwan, J. R. (2006). "Associations between pain, function, and radiographic features in osteoarthritis of the knee." Arthritis Rheum 54(1): 230-5.
    • Szebenyi, G. and Fallon, J. F. (1999). "Fibroblast growth factors as multifunctional signaling factors." Int Rev Cytol 185: 45-106.
    • Takagi, T., Tsao, P. W., Totsuka, R., Suzuki, T., Murata, T. and Takata, I. (1998). "Dexamethasone prevents the decrease of bone mineral density in type II collagen-induced rat arthritis model." Jpn J Pharmacol 78(2): 225-8.
    • Tanaka, E., Aoyama, J., Miyauchi, M., Takata, T., Hanaoka, K., Iwabe, T. and Tanne, K. (2005). "Vascular endothelial growth factor plays an important autocrine/paracrine role in the progression of osteoarthritis." Histochem Cell Biol 123(3): 275-81.
    • Tetlow, L. C., Adlam, D. J. and Woolley, D. E. (2001). "Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes." Arthritis Rheum 44(3): 585-94.
    • Thonar, E. J., Masuda, K., Lenz, M. E., Hauselmann, H. J., Kuettner, K. E. and Manicourt, D. H. (1995). "Serum markers of systemic disease processes in osteoarthritis." J Rheumatol Suppl 43: 68-70.
    • Uchii, M., Tamura, T., Suda, T., Kakuni, M., Tanaka, A. and Miki, I. (2008). "Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis." Arthritis Res Ther 10(4): R90.
    • Valdes, A. M., Van Oene, M., Hart, D. J., Surdulescu, G. L., Loughlin, J., Doherty, M. and Spector, T. D. (2006). "Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women." Arthritis Rheum 54(2): 533-9.
    • Van Arman, C. G., Carlson, R. P., Risley, E. A., Thomas, R. H. and Nuss, G. W. (1970). "Inhibitory effects of indomethacin, aspirin and certain other drugs on inflammations induced in rat and dog by carrageenan, sodium urate and ellagic acid." J Pharmacol Exp Ther 175(2): 459-68.
    • Van Arman, C. G., Nuss, G. W. and Risley, E. A. (1973). "Interactions of aspirin, indomethacin and other drugs in adjuvant-induced arthritis in the rat." J Pharmacol Exp Ther 187(2): 400-14.
    • van der Kraan, P. M., Vitters, E. L., van Beuningen, H. M., van de Putte, L. B. and van den Berg, W. B. (1990). "Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis." J Exp Pathol (Oxford) 71(1): 19-31.
    • van Lent, P. L., Blom, A. B., van der Kraan, P., Holthuysen, A. E., Vitters, E., van Rooijen, N., Smeets, R. L., Nabbe, K. C. and van den Berg, W. B. (2004). "Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation." Arthritis Rheum 50(1): 103-11.
    • Walsh, D. A., Yousef, A., McWilliams, D. F., Hill, R., Hargin, E. and Wilson, D. (2009). "Evaluation of a Photographic Chondropathy Score (PCS) for pathological samples in a study of inflammation in tibiofemoral osteoarthritis." Osteoarthritis Cartilage 17(3): 304-12.
    • Wang, H. M. and Zhang, G. Y. (2005). "Indomethacin suppresses growth of colon cancer via inhibition of angiogenesis in vivo." World J Gastroenterol 11(3): 340-3.
    • Waseem, N. H. and Lane, D. P. (1990). "Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form." J Cell Sci 96 ( Pt 1): 121-9.
    • Wilhelmi, G. and Faust, R. (1976). "Suitability of the C57 black mouse as an experimental animal for the study of skeletal changes due to ageing, with special reference to osteo-arthrosis and its response to tribenoside." Pharmacology 14(4): 289-96.
    • Williams, J. M. and Brandt, K. D. (1985). "Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage." Arthritis Rheum 28(11): 1267-74.
    • Wilson, A. S., Legg, P. G. and McNeur, J. C. (1969). "Studies on the innervation of the medial meniscus in the human knee joint." Anat Rec 165(4): 485-91.
    • Wolfensohn, S. and Lloyd, M. (2003). Handbook of Laboratory Animal Management and Welfare (3rd Edition). Oxford, Blackwell Publishing.
    • Woods, C. G., Greenwald, A. S. and Haynes, D. W. (1970). "Subchondral vascularity in the human femoral head." Ann Rheum Dis 29(2): 138-42.
    • Yamashita, A., Yonemitsu, Y., Okano, S., Nakagawa, K., Nakashima, Y., Irisa, T., Iwamoto, Y., Nagai, Y., Hasegawa, M. and Sueishi, K. (2002). "Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats." J Immunol 168(1): 450-7.
    • Yusuf, E., Kortekaas, M. C., Watt, I., Huizinga, T. W. and Kloppenburg, M. (2010). "Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review." Ann Rheum Dis.
    • Zanetti, M., Bruder, E., Romero, J. and Hodler, J. (2000). "Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings." Radiology 215(3): 835-40.
    • Zhang, W., Doherty, M., Peat, G., Bierma-Zeinstra, M. A., Arden, N. K., Bresnihan, B., HerreroBeaumont, G., Kirschner, S., Leeb, B. F., Lohmander, L. S., Mazieres, B., Pavelka, K., Punzi, L., So, A. K., Tuncer, T., Watt, I. and Bijlsma, J. W. (2010). "EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis." Ann Rheum Dis 69(3): 483-9.
    • Zhang, W., Nuki, G., Moskowitz, R. W., Abramson, S., Altman, R. D., Arden, N. K., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., Dougados, M., Hochberg, M., Hunter, D. J., Kwoh, K., Lohmander, L. S. and Tugwell, P. (2010). "OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009." Osteoarthritis Cartilage 18(4): 476-99.
    • 4 ml 396 ml
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Cite this article